Literature DB >> 18930569

Risk of CKD in Australian indigenous and nonindigenous children: a population-based cohort study.

Leigh Haysom1, Rita Williams, Elisabeth Hodson, Pamela Lopez-Vargas, L Paul Roy, David Lyle, Jonathan C Craig.   

Abstract

BACKGROUND: Aboriginal Australians have a 9-fold increased risk of end-stage renal disease. There is no information about the natural history and risk of chronic kidney disease (CKD) in Aboriginal and non-Aboriginal children. STUDY
DESIGN: Using a prospective study design, we aimed to determine the prevalence of persistent markers and risk factors for CKD in Australian Aboriginal and non-Aboriginal children and whether Aboriginal children are at increased risk of persistent markers of CKD after accounting for sociodemographic differences. SETTING & PARTICIPANTS: Children were enrolled from elementary schools throughout New South Wales. PREDICTOR: Aboriginal (Aboriginal and Torres Strait Islander Australians) versus non-Aboriginal ethnicity. OUTCOMES & MEASUREMENTS: Urine analysis, height, weight, blood pressure, birth weight, and sociodemographic status were measured at baseline and 2-year follow-up. Albuminuria was defined as albumin-creatinine ratio of 3.4 mg/mmol or greater, hematuria as 25 or greater red blood cells/microL (>or=1+), obesity as body mass index of 2 SDs or greater, and systolic and diastolic hypertension as blood pressure greater than the 90th percentile.
RESULTS: 2,266 children (55.1% Aboriginal; 51.0% boys; mean age, 8.9 +/- 2.0 years [SD] years) were enrolled at baseline. Early markers and predictors of CKD at baseline were frequent: hematuria (5.5%), albuminuria (7.3%), obesity (7.1%), systolic hypertension (7.2%), and diastolic hypertension (5.8%). 1,432 children (63%) were available for retesting at 2-year follow-up (54.0% Aboriginal; 50.5% boys; mean age, 10.5 +/- 2.0 years). Persistent obesity (5.3%) was frequent, but persistent markers of CKD were infrequent (systolic hypertension, 1.1%; diastolic hypertension, 0.2%; hematuria, 1.1%; and albuminuria, 1.5%). Although there were more Aboriginal than non-Aboriginal children with baseline hematuria (7.1% versus 3.6%; P = 0.001), after adjustment for age, sex, birth weight, and sociodemographic status, there was no increased risk of persistent hematuria, albuminuria, obesity, or hypertension in Aboriginal children. LIMITATIONS: Persistent markers of CKD were much less frequent than anticipated, which may have affected study power. The group lost at follow-up was older children, which may have biased results.
CONCLUSIONS: Overall, only 20% of children found to have markers of early CKD had persistent abnormalities (diastolic and systolic hypertension, albuminuria, and hematuria) 2 years later, equivalent to a population point prevalence of 1% to 2% in children with a mean age of 10 years. Aboriginal children had greater rates of baseline and transient hematuria, but no increased risk of persistent markers of CKD, suggesting that adolescence and young adulthood is a critical time for preventative strategies.

Entities:  

Mesh:

Year:  2008        PMID: 18930569     DOI: 10.1053/j.ajkd.2008.08.004

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  8 in total

1.  Can childhood obesity influence later chronic kidney disease?

Authors:  Lyda Jadresic; Richard J Silverwood; Sanjay Kinra; Dorothea Nitsch
Journal:  Pediatr Nephrol       Date:  2018-11-10       Impact factor: 3.714

2.  The differential effect of socio-economic status, birth weight and gender on body mass index in Australian Aboriginal Children.

Authors:  S Kim; P Macaskill; L A Baur; E M Hodson; J Daylight; R Williams; R Kearns; N Vukasin; D M Lyle; J C Craig
Journal:  Int J Obes (Lond)       Date:  2016-04-28       Impact factor: 5.095

3.  'Next Generation Youth Well-being Study:' understanding the health and social well-being trajectories of Australian Aboriginal adolescents aged 10-24 years: study protocol.

Authors:  Lina Gubhaju; Emily Banks; James Ward; Catherine D'Este; Rebecca Ivers; Robert Roseby; Peter Azzopardi; Anna Williamson; Catherine Chamberlain; Bette Liu; Cheri Hotu; Jacqueline Boyle; Bridgette McNamara; Sandra J Eades
Journal:  BMJ Open       Date:  2019-03-12       Impact factor: 2.692

4.  Risk Factors Associated With Abnormal Urinalysis in Children.

Authors:  Xuhui Zhong; Jie Ding; Zheng Wang; Yan Gao; Yubin Wu; Ying Shen; Hongmei Song; Zhengyan Zhao; Xinxin Chen; Puhong Zhang; Guobin Xu; Chen Yao; Hui Zhang; Fu Zhong; Ying Tang; Hui Wang; Wei Wang; Wenhao Li; Wanxia Zhang; Sainan Zhu; Meixia Shang
Journal:  Front Pediatr       Date:  2021-03-25       Impact factor: 3.418

5.  Impact of a screen, triage and treat program for identifying chronic disease risk in Indigenous children.

Authors:  Kara L Frejuk; Oksana Harasemiw; Paul Komenda; Barry Lavallee; Lorraine McLeod; Caroline Chartrand; Michelle Di Nella; Thomas W Ferguson; Heather Martin; Brandy Wicklow; Allison B Dart
Journal:  CMAJ       Date:  2021-09-13       Impact factor: 8.262

6.  Screening for kidney disease in Indigenous Canadian children: The FINISHED screen, triage and treat program.

Authors:  Allison Dart; Barry Lavallee; Caroline Chartrand; Lorraine McLeod; Thomas W Ferguson; Navdeep Tangri; Audrey Gordon; Tom Blydt-Hansen; Claudio Rigatto; Paul Komenda
Journal:  Paediatr Child Health       Date:  2018-04-14       Impact factor: 2.253

7.  Reported sources of health inequities in Indigenous Peoples with chronic kidney disease: a systematic review of quantitative studies.

Authors:  Tania Huria; Suzanne G Pitama; Lutz Beckert; Jaquelyne Hughes; Nathan Monk; Cameron Lacey; Suetonia C Palmer
Journal:  BMC Public Health       Date:  2021-07-23       Impact factor: 3.295

8.  Pediatric chronic kidney disease rates in Southern Israel are higher than reported.

Authors:  Daniel Landau; Ruth Schreiber; Anya Kleinman; Alina Vodonos; Hannah Shalev
Journal:  F1000Res       Date:  2013-09-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.